日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

您現(xiàn)在的位置: > Language Tips > Audio & Video > Special Speed News  
 





  Once-daily pill could simplify HIV treatment
[ 2006-02-06 15:57 ]


I’m Steve Ember with the VOA Special English Health Report.


Myers Squibb and Gilead Sciences have combined many H.I.V. drugs into a single pill
Sometimes the best medicine is more than one kind of medicine. Malaria, tuberculosis and H.I.V./AIDS, for example, are all treated with combinations of drugs.

But that can mean a lot of pills to take. It would be simpler if drug companies combined all the medicines into a single pill, taken just once a day.

Now, two companies say they have done that for people just starting treatment for H.I.V., the virus that causes AIDS. The companies are Bristol-Myers Squibb and Gilead Sciences.

They have developed a single pill that combines three drugs currently on the market. Bristol-Myers Squibb sells one of them under the name Sustiva. Gilead combined the others, Emtriva and Viread, into a single pill in two thousand four.

Combining drugs involves more than technical issues. It also involves issues of competition if the drugs are made by different companies. The new once-daily pill is the result of what is described as the first joint venture agreement of its kind in the treatment of H.I.V.

In January the New England Journal of Medicine published a study of the new pill. Researchers compared its effectiveness to that of the widely used combination of Sustiva and Combivir. Combivir contains two drugs, AZT and 3TC. The researchers say that after one year of treatment, the new pill suppressed H.I.V. levels in more patients and with fewer side effects.

Gilead paid for the study. Professor Joel Gallant at the Johns Hopkins School of Medicine in Baltimore, Maryland, led the research. He is a paid adviser to Gilead and Bristol-Meyers Squibb as well as the maker of Combivir, GlaxoSmithKline.

GlaxoSmithKline reacted to the findings by saying that a single study is of limited value. It says the effectiveness of Combivir has been shown in each of more than fifty studies.

The price of the new once-daily pill has not been announced. But Gilead and Bristol-Myers Squibb say they will provide it at reduced cost to developing countries.

They plan in the next few months to ask the United States Food and Drug Administration to approve the new pill.

There are limits to who could take it because of the different drugs it contains. For example, pregnant women are told not to take Sustiva because of the risk of birth disorders.

Experts say more than forty million people around the world are living with H.I.V.

This VOA Special English Health Report was written by Cynthia Kirk. Read and listen to our reports at voaspecialenglish.com. I’m Steve Ember.

Vocabulary

 

 

 
 
 




主站蜘蛛池模板: 国产精品夜色一区二区三区 | 理论片午午伦夜理片在线播放 | 99久久99| 欧美性xxxxx极品老少 | 亚洲午夜av久久乱码 | 色拍拍视频 | 男女网| 看全色黄大色黄大片爽一次 | 国产日韩一区二区三区在线观看 | 欧美日韩三区 | 欧美久久亚洲精品 | 国产成人一级片 | 韩国资源视频一区二区三区 | 欧美成人精品不卡视频在线观看 | 亚洲一区二区中文字幕 | 欧美a级成人淫片免费看 | 69久久国产精品热88人妻 | 五月婷婷在线播放 | 天天插天天干天天射 | 欧美激情免费观看一区 | 两性午夜视频 | 欧美一级特黄毛片免费 | 欧美亚洲一区二区三区在线 | 日日碰狠狠添天天爽五月婷 | 欧美在线播放一区 | 毛片资源 | 国产中文视频 | 99热99色| 日韩在线观看中文 | 午夜激情影院 | 婷婷视频在线观看 | 中文字幕亚洲综合 | 男女污网站 | 农村寡妇偷人高潮A片小说 午夜爱爱爱爱爽爽爽网站免费 | 国产黄色在线观看 | 欧美日韩中文在线 | 在线91| 在线播放国产一区二区三区 | 色偷偷亚洲男人 | 性爱视频在线免费 | 国产毛片a级|